Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Miscarriage mystery: 225 women to help scientists find answers

NCT ID NCT07293819

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

The FIRST-CARE study is a research project in Barcelona that will follow 225 women who have had a miscarriage in the first 14 weeks of pregnancy. Researchers will look at genetic, hormonal, immune, and other factors to better understand why miscarriages happen. The goal is to improve diagnosis and create personalized care plans for women and couples.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could lead to better diagnostic tools and personalized care plans for women who experience miscarriage, reducing emotional burden and improving reproductive health outcomes.
What could go wrong
This is an observational study, not a treatment trial, so it won't directly provide new therapies. Results may take time to translate into clinical practice, and the sample size is modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 225 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2025

Expected to finish

Jun 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Women aged 18 years or older with a diagnosis of first-trimester missed miscarriage (gestational age \<14 weeks) will be enrolled. The study population will include two cohorts: women experiencing their first miscarriage and women with a history of recurrent pregnancy loss (defined as two or more previous first-trimester miscarriages). Participants will be recruited at the Hospital de la Santa Creu i Sant Pau (Barcelona, Spain) from outpatient and emergency gynecology services. Male partners will be invited to participate in selected assessments when applicable.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Female participants: Inclusion Criteria: * Women aged 18 years or older. * Diagnosis of missed miscarriage in the first trimester (\<14 weeks of gestation) confirmed by ultrasound. * Presence of an intrauterine pregnancy with fetal demise (clinical pregnancy loss). * Willing and able to provide written informed consent. * Ability to understand and complete study procedures. Exclusion Criteria: * Multiple pregnancy (twins or more). * Ectopic pregnancy. * Molar pregnancy (complete or partial hydatidiform mole). * Ongoing pregnancy with fetal cardiac activity. * Inability or unwillingness to comply with study procedures or follow-up. Male participants: no specific inclusion or exclusion criteria will apply to male partners, since the main inclusion criteria is a clinical pregnancy loss.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Miscarriage in first trimester are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Abortion, Spontaneous

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Hospital de la Santa Creu i Sant Pau

    NOT_YET_RECRUITING

    Barcelona, Barcelona, 08025, Spain

  • Hospital de la Santa Creu i Sant Pau

    RECRUITING

    Barcelona, Barcelona, 08025, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.